• Inflammatory biomarkers are associated with aetiology and predict outcomes in community-acquired pneumonia: Results of a 5-year follow-up cohort study 

      Siljan, William Ward; Holter, Jan Cato; Michelsen, Annika; Nymo, Stig Haugset; Lauritzen, Trine; Oppen, Kjersti; Husebye, Einar; Ueland, Thor; Mollnes, Tom Eirik; Aukrust, Pål; Heggelund, Lars (Journal article; Peer reviewed, 2019)
      <b>Background</b><br> Biomarkers may facilitate clinical decisions in order to guide antimicrobial treatment and prediction of prognosis in community-acquired pneumonia (CAP). We measured serum C-reactive protein, procalcitonin (PCT) and calprotectin levels, and plasma pentraxin 3 (PTX3) and presepsin levels, along with whole-blood white cell counts, at three time-points, and examined their association ...
    • Target Values and Daytime Variation of Bone Turnover Markers in Monitoring Osteoporosis Treatment After Fractures 

      Borgen, Tove Tveitan; Solberg, Lene Bergendal; Lauritzen, Trine; Apalset, Ellen Margrete; Bjørnerem, Åshild Marit; Eriksen, Erik Fink (Journal article; Tidsskriftartikkel; Peer reviewed, 2022-04-22)
      The serum bone turnover markers (BTM) procollagen type 1 N-terminal propeptide (P1NP) and C-terminal cross-linking telopeptide of type 1 collagen (CTX) are recommended for monitoring adherence and response of antiresorptive drugs (ARD). BTM are elevated about 1 year after fracture and therefore BTM target values are most convenient in ARD treatment follow-up of fracture patients. In this prospective ...